Have your own idea? Try our Stock Screener
UPDATED Apr 16, 2025
Discover French Pharmaceuticals & Biotech Growth Stocks that are on the CAC. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDCL | €14.07 | 9.3% | 23.9% | €465.2m | €22.40 | PS35.2x | E115.3% | n/a | ||
ALTHX | €0.39 | -3.6% | -64.4% | €3.0m | €6.20 | PS1.3x | E112.8% | n/a | ||
AELIS | €1.18 | 3.5% | -90.9% | €16.1m | €7.50 | PS2.9x | E106.9% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
EAPI | €2.50 | 8.6% | -6.6% | €237.9m | €2.98 | PB0.2x | E66.5% | n/a | ||
NANO | €3.01 | 4.0% | -42.6% | €142.5m | €11.18 | PE-2.1x | E61.1% | n/a | ||
ALOPM | €0.49 | 20.7% | -67.0% | €9.0m | €2.00 | PS5.6x | E55.1% | n/a | ||
MAAT | €6.18 | 1.3% | -30.6% | €86.4m | €18.50 | PS26.9x | E44.5% | n/a | ||
IVA | €2.82 | 5.4% | -12.4% | €269.8m | €6.30 | PS18.3x | E39.0% | n/a | ||
ALDVI | €1.66 | 8.8% | -2.2% | €20.4m | €4.00 | PS6.1x | E37.5% | n/a | ||
IPH | €1.76 | 6.3% | -18.7% | €147.2m | €6.14 | PS7.3x | E36.3% | n/a | ||
ALERS | €24.26 | 3.2% | 59.0% | €243.7m | €30.00 | PE36.7x | E34.3% | n/a | ||
DIM | €191.35 | 23.0% | -23.0% | €18.6b | €245.08 | PE106.3x | E30.0% | 0.4% | ||
DBV | €1.28 | 6.8% | 0.9% | €131.5m | €1.74 | PS36.1x | E27.1% | n/a | ||
ALSEN | €0.23 | -41.0% | -67.2% | €69.1m | €2.50 | PS10.4x | E26.2% | n/a | ||
ALVAL | €1.01 | 1.3% | -73.6% | €16.0m | €3.80 | PS90.8x | E24.2% | n/a | ||
ABVX | €5.25 | 15.1% | -62.9% | €332.8m | €25.43 | PS30.8x | E23.3% | n/a | ||
ERF | €50.54 | 8.5% | -14.2% | €9.2b | €58.13 | PE25.8x | E22.8% | 1.2% | ||
BOI | €23.95 | 1.9% | -28.7% | €415.8m | €25.00 | PE17.6x | E21.1% | 5.6% | ||
VLA | €3.00 | 6.5% | -16.6% | €487.5m | €6.75 | PS2.9x | E17.7% | n/a | ||
PHXM | €0.71 | 3.8% | -75.9% | €7.1m | €4.90 | PS3.3x | E17.1% | n/a | ||
ALCLS | €1.35 | 19.7% | -42.5% | €97.2m | €6.50 | PS2.2x | E16.4% | n/a | ||
IPN | €94.80 | 1.9% | -10.9% | €7.8b | €126.33 | PE21.9x | E14.3% | 1.5% |